 |
Cardiovascular Morbidity and Mortality in Patients with Diabetes in the EUROPA Study: Results from the PERSUADE SubstudyPresented by Prof. Kim M. Fox
This EUROPA substudy shows that in diabetics, perindopril offers a similar relative risk reduction, and a greater absolute benefit, compared with the main study population of patients with stable coronary disease without heart failure. The effect of perindopril in diabetics appeared to be independent of the reduction in blood pressure achieved by the drug.
Magnet Therapy and the Autonomic Nervous SystemPresented by Benjamin J. Scherlag, PhD
The therapeutic use of magnets have been promoted for various medical conditions. What is less well known is the use of electromagnetic fields (EMFs) for the diagnosis and treatment of ailments using established scientific protocols. In this study, investigators applied specific, low-level EMFs to the cervical vagosympathetic trunks, which provide the major autonomic nerve inputs to the heart.
Late-Breaking Clinical Trials IIIPresented by Prof. Kim M. Fox, MD
Thomas A. Pearson, MD, PhD, FACC
Peter H. Stone, MD, FACC
Kim A. Eagle, MD, FACC
John J. Mahmarian, MD, FACC
This summary highlights key data from the PERSUADE, INSPIRE and other important trials.
EASE Trial: Ezetimibe Add-on to Statin for Effectiveness TrialPresented by Thomas A. Pearson, MD, PhD
The Ezetimibe Add-on to Statin for Effectiveness (EASE) trial was undertaken to examine the effectiveness and safety of ezetimibe, 10 mg, compared with placebo, added to any statin brand and dose in patients who were not at their NCEP ATP III LDL cholesterol goal despite statin monotherapy.
The Duke Treadmill Score and Cardiac Mortality in Asymptomatic Women: The St. James Women Take Heart ProjectPresented by Martha Gulati, MD, MS
|
|
|
